| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.5 |